Clinical Investigations in Critical Care: ArticlesA Trial of Antioxidants N-acetylcysteine and Procysteine (cas 19771-63-2) in ARDS
-
Add time:09/04/2019 Source:sciencedirect.com
ObjectiveTo determine the levels of glutathione and cysteine in patients with ARDS and examine the effect of treatment with N-acetylcysteine (NAC) and L-2-oxothiazolidine-4-carboxylate (Procysteine (cas 19771-63-2); Clintec Technologies Inc; Chicago [OTZ]) on these levels and on common physiologic abnormalities, and organ dysfunction associated with ARDS.
We also recommend Trading Suppliers and Manufacturers of Procysteine (cas 19771-63-2). Pls Click Website Link as below: cas 19771-63-2 suppliers
Prev:Toxicity evaluations of l-cysteine and Procysteine (cas 19771-63-2)™, a cysteine prodrug, given once intravenously to neonatal rats
Next:Determination of l-2-oxothiazolidine-4-carboxylic acid (Procysteine (cas 19771-63-2)®) in human plasma by high-performance liquid chromatography) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of l-2-oxothiazolidine-4-carboxylic acid (Procysteine (cas 19771-63-2)®) in human plasma by high-performance liquid chromatography09/05/2019
- Toxicity evaluations of l-cysteine and Procysteine (cas 19771-63-2)™, a cysteine prodrug, given once intravenously to neonatal rats09/03/2019
- Research communicationProtection of the ischemic rat heart by Procysteine (cas 19771-63-2) and amino acids☆09/02/2019